FORM 4
[ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).         
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
                                                                                  
OMB APPROVAL
OMB Number: 3235-0287
Expires: February 28, 2011
Estimated average burden
hours per response... 0.5
                      
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public
Utility Holding Company Act of 1935 or Section 30(f) of the Investment Company Act of 1940
                      

1. Name and Address of Reporting Person *

HART JOHN P 		2. Issuer Name and Ticker or Trading Symbol

NOVAMED INC [ NOVA ] 		5. Relationship of Reporting Person(s) to Issuer (Check all applicable)

_____ Director                      _____ 10% Owner
__ X __ Officer (give title below)      _____ Other (specify below)
VP, Corporate Controller
(Last)          (First)          (Middle)

333 W. WACKER DR., SUITE 1010 		3. Date of Earliest Transaction (MM/DD/YYYY)

5/21/2010
(Street)

CHICAGO, IL 60606
(City)        (State)        (Zip)
4. If Amendment, Date Original Filed (MM/DD/YYYY)

 
6. Individual or Joint/Group Filing (Check Applicable Line)

_ X _ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1.Title of Security
(Instr. 3) 		2. Trans. Date 2A. Deemed Execution Date, if any 3. Trans. Code
(Instr. 8) 		4. Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5) 		5. Amount of Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 3 and 4) 		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock   5/21/2010     F    108   D (8) $3.17   39517   (5) D    

Table II - Derivative Securities Beneficially Owned ( e.g. , puts, calls, warrants, options, convertible securities)
1. Title of Derivate Security
(Instr. 3) 		2. Conversion or Exercise Price of Derivative Security 3. Trans. Date 3A. Deemed Execution Date, if any 4. Trans. Code
(Instr. 8) 		5. Number of Derivative Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5) 		6. Date Exercisable and Expiration Date 7. Title and Amount of Securities Underlying Derivative Security
(Instr. 3 and 4) 		8. Price of Derivative Security
(Instr. 5) 		9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Stock Option (right to buy)   $2.039                      (1) 9/29/2013   Common Stock   60000     25000   D    
Stock Option (right to buy)   $4.45                      (2) 3/16/2014   Common Stock   25000     0   D    
Stock Option (right to buy)   $5.96                      (3) 6/16/2015   Common Stock   30000     0   D    
Stock Option (right to buy)   $6.87                      (4) 6/20/2016   Common Stock   17500     0   D    
Stock Option (right to buy)   $7.35                      (6) 2/21/2017   Common Stock   17500     0   D    
Stock Option (right to buy)   $2.75                      (7) 2/18/2019   Common Stock   27273     0   D    

Explanation of Responses:
( 1)  Subject to certain restrictions, 7,500 of these options vested on 3/28/04, with the remainder vesting 1,250 per month starting on 4/28/04.
( 2)  Subject to certain restrictions, 3,125 of these options vested on 9/16/04, with the remainder vesting 520 per month starting on 10/16/04.
( 3)  Subject to certain restrictions, 3,750 of these options vested on 12/17/05, with the remainder vesting 625 per month starting on 1/17/06.
( 4)  Subject to certain restrictions, 2,188 of these options vested on 12/20/06 with the remainder vesting approximately 365 per month starting on 1/20/07.
( 5)  Includes 29,578 restricted shares of common stock.
( 6)  Subject to certain restrictions, 2,188 of these options vested on 8/21/07 with the remainder vesting approximately 365 per month starting on 9/21/07.
( 7)  Subject to certain restrictions, 3,409 of these options vested on 8/18/09 with the remainder vesting approximately 568 per month starting on 9/18/09.
( 8)  Represents the disposition of shares to the Issuer to fund the Reporting Person's tax withholding obligations relating to the vesting on 5/21/2010 of 365 shares of a restricted stock award as permitted pursuant to the terms of the award.

Reporting Owners
Reporting Owner Name / Address
Relationships
Director 10% Owner Officer Other
HART JOHN P
333 W. WACKER DR.
SUITE 1010
CHICAGO, IL 60606

VP, Corporate Controller

Signatures
/s/ JOHN P. HART 5/25/2010
** Signature of Reporting Person Date


Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4(b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.
Novamed (MM) (NASDAQ:NOVAD)
과거 데이터 주식 차트
부터 5월(5) 2024 으로 6월(6) 2024 Novamed (MM) 차트를 더 보려면 여기를 클릭.
Novamed (MM) (NASDAQ:NOVAD)
과거 데이터 주식 차트
부터 6월(6) 2023 으로 6월(6) 2024 Novamed (MM) 차트를 더 보려면 여기를 클릭.